日本厚生勞動(dòng)省和武田制藥8月25日表示,國(guó)內(nèi)幾個(gè)疫苗接種中心報(bào)告稱在莫德納新冠疫苗瓶中發(fā)現(xiàn)異物,因此決定暫停使用超過(guò)163萬(wàn)劑的該款疫苗。
Takeda, which is in charge of sales and distribution of the Moderna shot in Japan, said it had informed Moderna and "requested an urgent investigation". Takeda did not detail the nature of the contamination, but said it had not so far received any reports of health concerns arising from affected doses.
武田制藥已要求美國(guó)莫德納公司對(duì)此事進(jìn)行緊急調(diào)查。負(fù)責(zé)莫德納新冠疫苗在日本分銷(xiāo)的武田制藥沒(méi)有詳細(xì)說(shuō)明異物的性質(zhì),但表示目前尚未收到任何該款受影響疫苗引起健康問(wèn)題的報(bào)告。
The health ministry said it would work with Takeda to secure alternative doses to avoid disruption to the country's vaccine program.
日本厚生勞動(dòng)省表示,將與武田制藥合作,確保替代疫苗的供應(yīng),以避免日本疫苗接種進(jìn)程中斷。
Around 43% of Japan's population is currently fully vaccinated, but the country is battling a record surge of virus cases driven by the more contagious Delta variant.
目前,日本約43%的人口已經(jīng)完成了新冠疫苗接種,但日本正在抗擊由更具傳染性的德?tīng)査局暌l(fā)的創(chuàng)紀(jì)錄的病例激增。